Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis

Neurology

Volumn 53, Issue SUPPL. 3, 1999, Pages

  Rovaris, Marco ^a   Horsfield, Mark A ^b   Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISABILITY; DISEASE ACTIVITY; HISTOGRAM; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 0033595546     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994;36:S97-S99.
2. McGowan JC, Filippi M, Campi A, Grossman RI. Magnetisation transfer imaging: theory and application to multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64(suppl 1):S66-S69.
3. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482.
4. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR imaging in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;96:511-515.
5. Hiehle JF, Lenkinski RE, Grossman RJ, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994;32:285-293.
6. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
7. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.
8. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with T2-weighted images. J Neurol 1997;244:266-270.
9. van Waesberghe JHTM, van Buchem MA, Filippi M, et al. MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note). AJNR Am J Neuroradiol 1998;19:1857-1862.
10. Filippi M, Miller DH. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 1996;9:178-186.
11. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334.
12. van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288.
13. van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization MR. AJNR Am J Neuroradiol 1998;19:675-683.
14. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-766.
15. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS. Brain 1993;116:1077-1094.
16. Kermode AG, Tofts P, Thompson AJ, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40:229-235.
17. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16: 225-231.
18. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann. Neurol 1994;36:62-67.
19. Campi A, Filippi M, Gerevini S, et al. Multiple white matter lesions of the brain. Magnetization transfer ratios in systemic lupus erythematosus and multiple sclerosis. Int J Neuroradiol 1996;2:134-140.
20. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690.
21. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1997;47:1469-1476.
22. Hiehle JF, Grossman RI, Ramer KN, et al. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and non-enhanced T1-weighted images. AJNR Am J Neuroradiol 1995; 16:69-77.
23. van Waesberghe JHTM, Castelijns JA, Scheltens P, et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 1997;15:155-162.
24. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
25. Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: Relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049.
26. Campi A, Filippi M, Comi G, Scotti G, Gerevini S, Dousset V. Magnetization transfer ratios of contrast-enhancing and non-enhancing lesions in multiple sclerosis. Neuroradiology 1996; 38:115-119.
27. Filippi M, Rocca MA, Rizzo G, et al. Magnetization transfer ratios in MS lesions enhancing after different doses of gadolinium. Neurology 1998;50:1289-1293.
28. Dousset V, Gayou A, Brochet B, Caille JM. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 1998;51:1150-1155.
29. Lai HM, Davie CA, Gass A, et al. Serial magnetization transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311.
30. Silver NC, Lai M, Symms MR, Barker GJ, McDonald WI, Miller DH. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998; 51:758-764.
31. Prineas JW, Barnard RO, Kwon EE, Shorer LL, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993;33:137-151.
32. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996;46: 379-384.
33. Silver NC, Good CD, Barker GJ, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetisation transfer contrast and delayed imaging. Brain 1997;120:1149-1161.
34. Filippi M, Rovaris M, Capra R, et al. A multi-center longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis: implications for phase II clinical trials. Brain 1998;121:2011-2020.
35. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995;118: 1601-1612.
36. Paty DW, Li DKB, Oger JJF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994;36:S95-S96.
37. Gawne-Cain ML, O'Riordan JI, Coles A, Newell B, Thompson AJ, Miller DH. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid-attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry 1998;64:197-203.
38. Paty DW, Li DKB, MS/MRI Study Group, IFN-beta MS Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis 2: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667.
39. Zhao GJ, Li DKB, Wolinsky JS, et al. Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. J Neuroimaging 1997;7:1-7.
40. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608.
41. Filippi M, Rocca MA, Horsfield MA, Comi G. A one year study of new lesions in multiple sclerosis using monthly gadolinium-enhanced MRI: correlations with changes of T2 and magnetization transfer lesion loads. J Neurol Sci 1998;158:203-208.
42. Mastronardo G, Iannucci G, Rocca MA, et al. Correlations between clinical and MRI cerebellar involvement in multiple sclerosis: assessment with T2, T1 and MT histograms [abstract]. Neurology 1998;50(suppl 4):108.
43. Comi G, Rovaris M, Martinelli V, Santuccio G, Possa F, Filippi M. Conventional and non-conventional MRI findings in MS patients with and without frontal lobe dysfunction [abstract]. Multiple Sclerosis 1998;4:297.
44. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617.
45. Rovaris M, Iannucci G, Minicucci L, et al. Assessment of disease severity in multiple sclerosis patients with magnetization transfer histograms [abstract]. J Neurol 1998;245:444.
46. Phillips MD, Grossman RI, Miki Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1055-1060.